肿瘤研究与临床
腫瘤研究與臨床
종류연구여림상
CANCER RESEARCH AND CLINIC
2011年
12期
810-813
,共4页
刘西林%杨平玲%张永生%韩洁%朱晓玲%高萍
劉西林%楊平玲%張永生%韓潔%硃曉玲%高萍
류서림%양평령%장영생%한길%주효령%고평
甲状腺肿瘤%免疫组织化学%术中病理
甲狀腺腫瘤%免疫組織化學%術中病理
갑상선종류%면역조직화학%술중병리
Thyroid neoplasms%Immunohistochemistry%Intraoperative pathology
目的 探讨快速免疫组织化学(IHC)新方法在甲状腺肿瘤术中冷冻诊断中的应用价值.方法 采用MaxVision快速IHC一步法检测CK19、HBME-1 、Gla-3在甲状腺乳头状癌(PTC)及甲状腺良性病变组织冷冻切片中的表达,以冰剩组织MaxVision常规IHC作对照.结果 MaxVision快速IHC一步法在20 min内完成,三种标记阳性定位与常规IHC基本对应一致,表达部位CK19位于细胞质和细胞膜,Gla-3 、HBME-1以滤泡腔缘或(和)乳头表面为主,表达强度强于常规IHC.冷冻切片快速IHC CK19、HBME-1、Gla-3阳性表达率:良性病变(结节性甲状腺肿、慢性淋巴细胞性甲状腺炎、腺瘤)为0、10.7%(3/28)、0,PTC为94.9%(37/39)、92.3%(36/39)、92.3 %(36/39),三种标记在甲状腺良性病变与PTC间表达差异均有统计学意义(x2值分别为59.326、55.861、44.605,均P<0.05);同一病例两种以上标记阳性在良性病变为0,PTC为100%,差异有统计学意义(x2=67.000,P< 0.05).结论 MaxVision快速IHC一步法可以应用于术中冷冻诊断,联合检测CK19、HBME-1 、Gla-3对PTC术中冷冻诊断具有较高辅助诊断价值.
目的 探討快速免疫組織化學(IHC)新方法在甲狀腺腫瘤術中冷凍診斷中的應用價值.方法 採用MaxVision快速IHC一步法檢測CK19、HBME-1 、Gla-3在甲狀腺乳頭狀癌(PTC)及甲狀腺良性病變組織冷凍切片中的錶達,以冰剩組織MaxVision常規IHC作對照.結果 MaxVision快速IHC一步法在20 min內完成,三種標記暘性定位與常規IHC基本對應一緻,錶達部位CK19位于細胞質和細胞膜,Gla-3 、HBME-1以濾泡腔緣或(和)乳頭錶麵為主,錶達彊度彊于常規IHC.冷凍切片快速IHC CK19、HBME-1、Gla-3暘性錶達率:良性病變(結節性甲狀腺腫、慢性淋巴細胞性甲狀腺炎、腺瘤)為0、10.7%(3/28)、0,PTC為94.9%(37/39)、92.3%(36/39)、92.3 %(36/39),三種標記在甲狀腺良性病變與PTC間錶達差異均有統計學意義(x2值分彆為59.326、55.861、44.605,均P<0.05);同一病例兩種以上標記暘性在良性病變為0,PTC為100%,差異有統計學意義(x2=67.000,P< 0.05).結論 MaxVision快速IHC一步法可以應用于術中冷凍診斷,聯閤檢測CK19、HBME-1 、Gla-3對PTC術中冷凍診斷具有較高輔助診斷價值.
목적 탐토쾌속면역조직화학(IHC)신방법재갑상선종류술중냉동진단중적응용개치.방법 채용MaxVision쾌속IHC일보법검측CK19、HBME-1 、Gla-3재갑상선유두상암(PTC)급갑상선량성병변조직냉동절편중적표체,이빙잉조직MaxVision상규IHC작대조.결과 MaxVision쾌속IHC일보법재20 min내완성,삼충표기양성정위여상규IHC기본대응일치,표체부위CK19위우세포질화세포막,Gla-3 、HBME-1이려포강연혹(화)유두표면위주,표체강도강우상규IHC.냉동절편쾌속IHC CK19、HBME-1、Gla-3양성표체솔:량성병변(결절성갑상선종、만성림파세포성갑상선염、선류)위0、10.7%(3/28)、0,PTC위94.9%(37/39)、92.3%(36/39)、92.3 %(36/39),삼충표기재갑상선량성병변여PTC간표체차이균유통계학의의(x2치분별위59.326、55.861、44.605,균P<0.05);동일병례량충이상표기양성재량성병변위0,PTC위100%,차이유통계학의의(x2=67.000,P< 0.05).결론 MaxVision쾌속IHC일보법가이응용우술중냉동진단,연합검측CK19、HBME-1 、Gla-3대PTC술중냉동진단구유교고보조진단개치.
Objective To investigate the application of rapid immunohistochemical staining technique in intraoperative frozen section diagnosis of thyroid neoplasm. Methods MaxVision one-step rapid immunohistochemical staining technique was used to detect the expression of CK19,HBME-1,and Gal-3 in frozen section of papillary thyroid carcinoma (PTC) and thyroid benign lesions.MaxVision conventional immunohistochemistry of frozen remaining tissue was served as control.Results MaxVision one-step rapid immunohistochemical staining technique could be completed in 20 minutes.The positive localizations of three markers detected by rapid immunohistochemistry were similar to conventional immunohistochemistry, in general.The expression of CK19 was located in cytoplasm and cellular membrane.Gal-3 and HBME-1 were mainly detected in follicular luminal border and/or surface of papilla. The staining intensity in rapid immunohistochemistry was stronger than that in conventional immunohistochemistry. The positive rates of CK19,HBME-1,and Gal-3 by rapid immunohistochemistry in frozen sections were: 0 (0/28),10.7 % (3/28),0 (0/28),respectively,for benign lesions (nodular goiter,Hashimoto thyroiditis,thyroid adenoma); and 94.9 %(37/39),92.3 % (36/39),92.3 % (36/39),respectively,for PTC.The expression of three markers between thyroid benign lesions and PTC had a significant difference (x2 =59.326,55.861,44.605,all P < 0.001).In benign lesions,the rate of same case with two and more positive markers was 0,while in PTC it was 100 % and significantly different (x2 =67.000,P < 0.05).Conclusion MaxVision one-step rapid immunohistochemical staining technique could be applied in intraoperative frozen section diagnosis.Detecting CK19,HBME-1,and Gal-3 expression in intraoperative frozen section has an auxiliary value for diagnosis of PTC.